Company Biofarma-Vet Srl with Fiscal Code 11437486
recorded a turnover of 2024 of
52.379,
with a net profit of
1.362
and having an average number of employees of
1.
The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biofarma-Vet Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
22.594
26.414
27.278
32.093
34.252
43.294
35.000
40.137
46.964
52.379
Total Income - EUR
22.597
26.415
27.279
32.093
34.253
43.294
35.000
40.138
46.964
52.379
Total Expenses - EUR
22.600
25.528
27.401
31.204
33.603
39.222
34.273
39.207
44.158
50.556
Gross Profit/Loss - EUR
-3
887
-123
889
649
4.072
727
931
2.806
1.823
Net Profit/Loss - EUR
-681
623
-396
568
307
3.639
419
674
2.381
1.362
Employees
2
2
2
2
2
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.2%, from 46.964 euro in the year 2023, to 52.379 euro in 2024.
The Net Profit decreased by -1.006 euro, from 2.381 euro in 2023, to 1.362 in the last year.
Check the financial reports for the company - Biofarma-Vet Srl
Financial Rating - BIOFARMA-VET SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biofarma-Vet Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biofarma-Vet Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biofarma-Vet Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.510 euro in 2024 which includes Inventories of
7.680 euro, Receivables of
0 euro and cash availability of
2.830 euro.
The company's Equity was valued at
9.897 euro, while total Liabilities amounted to
1.022 euro.
Equity increased by 1.362 euro, from 8.583 euro in 2023, to 9.897 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biofarma-Vet Srl